Abstract

44063 Short Term Efficacy and Racial and Ethnic Diversity in Risankizumab Phase 3 Clinical Trials for Treatment of Moderate-to-Severe Plaque Psoriasis

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call